Ladan Teimoori-Toolabi

13PUBLICATIONS
13CO-AUTHORS
Molecular targetsProteins and peptidesGenetic immunologyGene and molecular therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 10, 2025
PTEN and p53 Combined Gene Therapy Promote Apoptosis and Chemosensitivity to Oxaliplatin in Colorectal Cancer: An In Vitro Study.

Narjes Nakhaee, Sirous Zeinali, Mahboubeh Kabiri

|May 15, 2025
Evolutionary and Structural Assessment of the Human Secreted Frizzled-Related Protein (SFRP) Family.

Ladan Mafakher, Elham Rismani, Ladan Teimoori-Toolabi

|May 14, 2025
HLA Polymorphisms and COVID-19 Susceptibility and Severity: Insights From an Iranian Patients Cohort.

Pooria Hakimi, Kasra Arbabi Zaboli, Mohammadreza Golbabapour-Samakoush

|Feb 11, 2025
Targeted cancer treatment using a novel EGFR-specific Fc-fusion peptide based on GE11 peptide.

Malihe Hallaji, Mojgan Allahyari, Ladan Teimoori-Toolabi

|Apr 28, 2023
Kallistatin as an inhibitory protein against colorectal cancer cells through binding to LRP6.

Behzad Shahbazi, Ladan Mafakher, Seyed Shahriar Arab

|Jun 22, 2022
Studying the potential of upregulated PTGS2 and VEGF-C besides hyper-methylation of PTGS2 promoter as biomarkers of Acute myeloid leukemia.

Masoumeh Kiani-Zadeh, Mohammad Reza Rezvany, Soodeh Namjoo

Pageof 3